Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fosun Pharma, Shanghai Pharma Deny Interest In Stada

Mar 14 2017

• By Ying Huang

Euro coins stacked like a king on a chess board

Related Content

Kite Flies CAR-T Into Asia With Daiichi Sankyo, Fosun Deals

Jan 11 2017

New Fosun Funds to Support Gland Bid, Growth, Lower Debt

Jun 08 2016

Hengrui Pursues Innovation Through New $100m US Spinoff

Jul 11 2016

Fosun Pitches For India’s Gland

May 17 2016

Incyte, Hengrui In 'Biggest Ever' China Pharma Out-Licensing Deal

Sep 04 2015

Large Caps To Lead China’s Outbound Pharma M&A

Jul 02 2015

Related Companies

STADA Arzneimittel AG

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Pharmaceutical Group Co., Ltd

Kite Pharma, Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

WuXi AppTec

Ambrx Biopharma, Inc.

Saladax Biomedical, Inc.

Alma Lasers Ltd.

Jiangsu Hengrui Pharmaceuticals

Incyte Corporation

Additional Topics

China Asia Pacific M & A Financing Commercial Companies BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window